Visacor

Země: Nový Zéland

Jazyk: angličtina

Zdroj: Medsafe (Medicines Safety Authority)

Aktivní složka:

Rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin;  

Dostupné s:

AstraZeneca Limited

INN (Mezinárodní Name):

Rosuvastatin calcium 41.6 mg (= 40 mg rosuvastatin)

Dávkování:

40 mg

Léková forma:

Film coated tablet

Složení:

Active: Rosuvastatin calcium 41.6mg equivalent to 40 mg rosuvastatin   Excipient: Calcium phosphate Crospovidone Hypromellose as Opadry Pink Iron oxide red as Opadry Pink Lactose monohydrate as Opadry Pink   Magnesium stearate Microcrystalline cellulose Titanium dioxide as Opadry Pink Triacetin as Opadry Pink

Jednotky v balení:

Blister pack, Al/Al foil, 30 tablets

Třída:

Prescription

Druh předpisu:

Prescription

Výrobce:

AstraZeneca UK Ltd

Terapeutické indikace:

VISACOR is indicated to: - Reduce elevated LDL-C, Total Cholesterol, triglycerides and to increase HDLcholesterol in patients with primary hypercholesterolemia (heterozygous familial and non familial) and mixed dyslipidaemia (Fredrickson Types IIa and IIb). - Treat isolated hypertriglyceridaemia (Fredrickson Type IV hyperlipidaemia). Reduce Total Cholesterol and LDL-C in patients with homozygous familial hypercholesterolemia, as an adjunct to diet and other lipid lowering treatments (eg. LDL apheresis) or alone if such treatments are unavailable.

Přehled produktů:

Package - Contents - Shelf Life: Blister pack, Al/Al foil - 30 tablets - 36 months from date of manufacture stored at or below 30°C

Datum autorizace:

2009-07-31